William Guyer - 01 Jul 2025 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Development Officer
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for William Guyer.
Issuer symbol
CORT
Transactions as of
01 Jul 2025
Transactions value $
-$5,186
Form type
4
Filing time
03 Jul 2025, 20:39:07 UTC
Previous filing
12 Jun 2025
Next filing
21 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Guyer William Chief Development Officer C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY /s/ Joseph Douglas Lyon, as attorney-in-fact for William Guyer. 03 Jul 2025 0001879013

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $2.17K +100 +1.82% $21.65 5.59K 01 Jul 2025 Direct
transaction CORT Common Stock Sale -$7.35K -100 -1.79% $73.51 5.49K 01 Jul 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Options Exercise $0 -100 -0.03% $0.00 390K 01 Jul 2025 Common Stock 100 $21.65 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction.
F2 Fully exercisable.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.